Name | k03861 |
---|---|
Synonyms |
1-{4-[(2-Amino-4-pyrimidinyl)oxy]phenyl}-3-{4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}urea
1-[4-(2-amino-pyrimidin-4-yloxy)-phenyl]-3-[4-(4-methyl-piperazin-1-ylmethyl)-3-rifluoromethyl-phenyl]-urea Urea, N-[4-[(2-amino-4-pyrimidinyl)oxy]phenyl]-N'-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]- 1-[4-(2-aminopyrimidine-4-yloxy)phenyl]-3-[4-(4-methyl-piperazin-1-ylmethyl)-3-trifluoromethyl-phenyl]urea |
Description | K03861 is a type II CDK2 inhibitor with Kd of 8.2 nM.K03861 inhibits CDK2 activity by competing with binding of activating cyclins. |
---|---|
Related Catalog | |
Target |
CDK2(C118L/A144C):9.7 nM (Kd) CDK2(A144C):15.4 nM (Kd) CDK2(C118L):18.6 nM (Kd) CDK2(WT):50 nM (Kd) CDK2(C118L/A144C-Cyclin B):134.1 nM (Kd) |
References |
[1]. Alexander LT et al. Type II Inhibitors Targeting CDK2. ACS Chem Biol. 2015 Sep 18;10(9):2116-25. |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C24H26F3N7O2 |
Molecular Weight | 501.504 |
Exact Mass | 501.210022 |
PSA | 108.64000 |
LogP | 3.41 |
Index of Refraction | 1.642 |
Storage condition | -20℃ |